Global Type 1 Diabetes Drugs Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 14 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

This report studies the global Type 1 Diabetes Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Type 1 Diabetes Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Type 1 Diabetes Drugs that contribute to its increasing demand across many markets.

The global Type 1 Diabetes Drugs market size is expected to reach $ 15740 million by 2029, rising at a market growth of 5.0% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Type 1 Diabetes Drugs total production and demand, 2018-2029, (K Units)
Global Type 1 Diabetes Drugs total production value, 2018-2029, (USD Million)
Global Type 1 Diabetes Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Type 1 Diabetes Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Type 1 Diabetes Drugs domestic production, consumption, key domestic manufacturers and share
Global Type 1 Diabetes Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Type 1 Diabetes Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Type 1 Diabetes Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Type 1 Diabetes Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lily, Adocia, Astellas Pharma, AstraZeneca, BHV Pharma, Biodel and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Type 1 Diabetes Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Type 1 Diabetes Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Type 1 Diabetes Drugs Market, Segmentation by Type
    Insulins
    Others

Global Type 1 Diabetes Drugs Market, Segmentation by Application
    Drugstore
    Hospital
    Others

Companies Profiled:
    Novo Nordisk
    Sanofi
    Eli Lily
    Adocia
    Astellas Pharma
    AstraZeneca
    BHV Pharma
    Biodel
    Boehringer Ingelheim
    Diamyd Therapeutics AB

Key Questions Answered
1. How big is the global Type 1 Diabetes Drugs market?
2. What is the demand of the global Type 1 Diabetes Drugs market?
3. What is the year over year growth of the global Type 1 Diabetes Drugs market?
4. What is the production and production value of the global Type 1 Diabetes Drugs market?
5. Who are the key producers in the global Type 1 Diabetes Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Type 1 Diabetes Drugs Introduction
    1.2 World Type 1 Diabetes Drugs Supply & Forecast
        1.2.1 World Type 1 Diabetes Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Type 1 Diabetes Drugs Production (2018-2029)
        1.2.3 World Type 1 Diabetes Drugs Pricing Trends (2018-2029)
    1.3 World Type 1 Diabetes Drugs Production by Region (Based on Production Site)
        1.3.1 World Type 1 Diabetes Drugs Production Value by Region (2018-2029)
        1.3.2 World Type 1 Diabetes Drugs Production by Region (2018-2029)
        1.3.3 World Type 1 Diabetes Drugs Average Price by Region (2018-2029)
        1.3.4 North America Type 1 Diabetes Drugs Production (2018-2029)
        1.3.5 Europe Type 1 Diabetes Drugs Production (2018-2029)
        1.3.6 China Type 1 Diabetes Drugs Production (2018-2029)
        1.3.7 Japan Type 1 Diabetes Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Type 1 Diabetes Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Type 1 Diabetes Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Type 1 Diabetes Drugs Demand (2018-2029)
    2.2 World Type 1 Diabetes Drugs Consumption by Region
        2.2.1 World Type 1 Diabetes Drugs Consumption by Region (2018-2023)
        2.2.2 World Type 1 Diabetes Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Type 1 Diabetes Drugs Consumption (2018-2029)
    2.4 China Type 1 Diabetes Drugs Consumption (2018-2029)
    2.5 Europe Type 1 Diabetes Drugs Consumption (2018-2029)
    2.6 Japan Type 1 Diabetes Drugs Consumption (2018-2029)
    2.7 South Korea Type 1 Diabetes Drugs Consumption (2018-2029)
    2.8 ASEAN Type 1 Diabetes Drugs Consumption (2018-2029)
    2.9 India Type 1 Diabetes Drugs Consumption (2018-2029)

3 World Type 1 Diabetes Drugs Manufacturers Competitive Analysis
    3.1 World Type 1 Diabetes Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Type 1 Diabetes Drugs Production by Manufacturer (2018-2023)
    3.3 World Type 1 Diabetes Drugs Average Price by Manufacturer (2018-2023)
    3.4 Type 1 Diabetes Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Type 1 Diabetes Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Type 1 Diabetes Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Type 1 Diabetes Drugs in 2022
    3.6 Type 1 Diabetes Drugs Market: Overall Company Footprint Analysis
        3.6.1 Type 1 Diabetes Drugs Market: Region Footprint
        3.6.2 Type 1 Diabetes Drugs Market: Company Product Type Footprint
        3.6.3 Type 1 Diabetes Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Type 1 Diabetes Drugs Production Value Comparison
        4.1.1 United States VS China: Type 1 Diabetes Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Type 1 Diabetes Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Type 1 Diabetes Drugs Production Comparison
        4.2.1 United States VS China: Type 1 Diabetes Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Type 1 Diabetes Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Type 1 Diabetes Drugs Consumption Comparison
        4.3.1 United States VS China: Type 1 Diabetes Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Type 1 Diabetes Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Type 1 Diabetes Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Type 1 Diabetes Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Type 1 Diabetes Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Type 1 Diabetes Drugs Production (2018-2023)
    4.5 China Based Type 1 Diabetes Drugs Manufacturers and Market Share
        4.5.1 China Based Type 1 Diabetes Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Type 1 Diabetes Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Type 1 Diabetes Drugs Production (2018-2023)
    4.6 Rest of World Based Type 1 Diabetes Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Type 1 Diabetes Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Type 1 Diabetes Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Type 1 Diabetes Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Type 1 Diabetes Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Insulins
        5.2.2 Others
    5.3 Market Segment by Type
        5.3.1 World Type 1 Diabetes Drugs Production by Type (2018-2029)
        5.3.2 World Type 1 Diabetes Drugs Production Value by Type (2018-2029)
        5.3.3 World Type 1 Diabetes Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Type 1 Diabetes Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Drugstore
        6.2.2 Hospital
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Type 1 Diabetes Drugs Production by Application (2018-2029)
        6.3.2 World Type 1 Diabetes Drugs Production Value by Application (2018-2029)
        6.3.3 World Type 1 Diabetes Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Details
        7.1.2 Novo Nordisk Major Business
        7.1.3 Novo Nordisk Type 1 Diabetes Drugs Product and Services
        7.1.4 Novo Nordisk Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Novo Nordisk Recent Developments/Updates
        7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Type 1 Diabetes Drugs Product and Services
        7.2.4 Sanofi Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Eli Lily
        7.3.1 Eli Lily Details
        7.3.2 Eli Lily Major Business
        7.3.3 Eli Lily Type 1 Diabetes Drugs Product and Services
        7.3.4 Eli Lily Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Eli Lily Recent Developments/Updates
        7.3.6 Eli Lily Competitive Strengths & Weaknesses
    7.4 Adocia
        7.4.1 Adocia Details
        7.4.2 Adocia Major Business
        7.4.3 Adocia Type 1 Diabetes Drugs Product and Services
        7.4.4 Adocia Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Adocia Recent Developments/Updates
        7.4.6 Adocia Competitive Strengths & Weaknesses
    7.5 Astellas Pharma
        7.5.1 Astellas Pharma Details
        7.5.2 Astellas Pharma Major Business
        7.5.3 Astellas Pharma Type 1 Diabetes Drugs Product and Services
        7.5.4 Astellas Pharma Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Astellas Pharma Recent Developments/Updates
        7.5.6 Astellas Pharma Competitive Strengths & Weaknesses
    7.6 AstraZeneca
        7.6.1 AstraZeneca Details
        7.6.2 AstraZeneca Major Business
        7.6.3 AstraZeneca Type 1 Diabetes Drugs Product and Services
        7.6.4 AstraZeneca Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 AstraZeneca Recent Developments/Updates
        7.6.6 AstraZeneca Competitive Strengths & Weaknesses
    7.7 BHV Pharma
        7.7.1 BHV Pharma Details
        7.7.2 BHV Pharma Major Business
        7.7.3 BHV Pharma Type 1 Diabetes Drugs Product and Services
        7.7.4 BHV Pharma Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 BHV Pharma Recent Developments/Updates
        7.7.6 BHV Pharma Competitive Strengths & Weaknesses
    7.8 Biodel
        7.8.1 Biodel Details
        7.8.2 Biodel Major Business
        7.8.3 Biodel Type 1 Diabetes Drugs Product and Services
        7.8.4 Biodel Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Biodel Recent Developments/Updates
        7.8.6 Biodel Competitive Strengths & Weaknesses
    7.9 Boehringer Ingelheim
        7.9.1 Boehringer Ingelheim Details
        7.9.2 Boehringer Ingelheim Major Business
        7.9.3 Boehringer Ingelheim Type 1 Diabetes Drugs Product and Services
        7.9.4 Boehringer Ingelheim Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Boehringer Ingelheim Recent Developments/Updates
        7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.10 Diamyd Therapeutics AB
        7.10.1 Diamyd Therapeutics AB Details
        7.10.2 Diamyd Therapeutics AB Major Business
        7.10.3 Diamyd Therapeutics AB Type 1 Diabetes Drugs Product and Services
        7.10.4 Diamyd Therapeutics AB Type 1 Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Diamyd Therapeutics AB Recent Developments/Updates
        7.10.6 Diamyd Therapeutics AB Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Type 1 Diabetes Drugs Industry Chain
    8.2 Type 1 Diabetes Drugs Upstream Analysis
        8.2.1 Type 1 Diabetes Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Type 1 Diabetes Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Type 1 Diabetes Drugs Production Mode
    8.6 Type 1 Diabetes Drugs Procurement Model
    8.7 Type 1 Diabetes Drugs Industry Sales Model and Sales Channels
        8.7.1 Type 1 Diabetes Drugs Sales Model
        8.7.2 Type 1 Diabetes Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Type 1 Diabetes Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Type 1 Diabetes Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Type 1 Diabetes Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Type 1 Diabetes Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Type 1 Diabetes Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Type 1 Diabetes Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Type 1 Diabetes Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Type 1 Diabetes Drugs Production Market Share by Region (2018-2023)
    Table 9. World Type 1 Diabetes Drugs Production Market Share by Region (2024-2029)
    Table 10. World Type 1 Diabetes Drugs Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Type 1 Diabetes Drugs Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Type 1 Diabetes Drugs Major Market Trends
    Table 13. World Type 1 Diabetes Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Type 1 Diabetes Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Type 1 Diabetes Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Type 1 Diabetes Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Type 1 Diabetes Drugs Producers in 2022
    Table 18. World Type 1 Diabetes Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Type 1 Diabetes Drugs Producers in 2022
    Table 20. World Type 1 Diabetes Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Type 1 Diabetes Drugs Company Evaluation Quadrant
    Table 22. World Type 1 Diabetes Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Type 1 Diabetes Drugs Production Site of Key Manufacturer
    Table 24. Type 1 Diabetes Drugs Market: Company Product Type Footprint
    Table 25. Type 1 Diabetes Drugs Market: Company Product Application Footprint
    Table 26. Type 1 Diabetes Drugs Competitive Factors
    Table 27. Type 1 Diabetes Drugs New Entrant and Capacity Expansion Plans
    Table 28. Type 1 Diabetes Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Type 1 Diabetes Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Type 1 Diabetes Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Type 1 Diabetes Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Type 1 Diabetes Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Type 1 Diabetes Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Type 1 Diabetes Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Type 1 Diabetes Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Type 1 Diabetes Drugs Production Market Share (2018-2023)
    Table 37. China Based Type 1 Diabetes Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Type 1 Diabetes Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Type 1 Diabetes Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Type 1 Diabetes Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Type 1 Diabetes Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Type 1 Diabetes Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Type 1 Diabetes Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Type 1 Diabetes Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Type 1 Diabetes Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Type 1 Diabetes Drugs Production Market Share (2018-2023)
    Table 47. World Type 1 Diabetes Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Type 1 Diabetes Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Type 1 Diabetes Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Type 1 Diabetes Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Type 1 Diabetes Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Type 1 Diabetes Drugs Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Type 1 Diabetes Drugs Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Type 1 Diabetes Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Type 1 Diabetes Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Type 1 Diabetes Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Type 1 Diabetes Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Type 1 Diabetes Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Type 1 Diabetes Drugs Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Type 1 Diabetes Drugs Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 62. Novo Nordisk Major Business
    Table 63. Novo Nordisk Type 1 Diabetes Drugs Product and Services
    Table 64. Novo Nordisk Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Novo Nordisk Recent Developments/Updates
    Table 66. Novo Nordisk Competitive Strengths & Weaknesses
    Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 68. Sanofi Major Business
    Table 69. Sanofi Type 1 Diabetes Drugs Product and Services
    Table 70. Sanofi Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Sanofi Recent Developments/Updates
    Table 72. Sanofi Competitive Strengths & Weaknesses
    Table 73. Eli Lily Basic Information, Manufacturing Base and Competitors
    Table 74. Eli Lily Major Business
    Table 75. Eli Lily Type 1 Diabetes Drugs Product and Services
    Table 76. Eli Lily Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Eli Lily Recent Developments/Updates
    Table 78. Eli Lily Competitive Strengths & Weaknesses
    Table 79. Adocia Basic Information, Manufacturing Base and Competitors
    Table 80. Adocia Major Business
    Table 81. Adocia Type 1 Diabetes Drugs Product and Services
    Table 82. Adocia Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Adocia Recent Developments/Updates
    Table 84. Adocia Competitive Strengths & Weaknesses
    Table 85. Astellas Pharma Basic Information, Manufacturing Base and Competitors
    Table 86. Astellas Pharma Major Business
    Table 87. Astellas Pharma Type 1 Diabetes Drugs Product and Services
    Table 88. Astellas Pharma Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Astellas Pharma Recent Developments/Updates
    Table 90. Astellas Pharma Competitive Strengths & Weaknesses
    Table 91. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 92. AstraZeneca Major Business
    Table 93. AstraZeneca Type 1 Diabetes Drugs Product and Services
    Table 94. AstraZeneca Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. AstraZeneca Recent Developments/Updates
    Table 96. AstraZeneca Competitive Strengths & Weaknesses
    Table 97. BHV Pharma Basic Information, Manufacturing Base and Competitors
    Table 98. BHV Pharma Major Business
    Table 99. BHV Pharma Type 1 Diabetes Drugs Product and Services
    Table 100. BHV Pharma Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. BHV Pharma Recent Developments/Updates
    Table 102. BHV Pharma Competitive Strengths & Weaknesses
    Table 103. Biodel Basic Information, Manufacturing Base and Competitors
    Table 104. Biodel Major Business
    Table 105. Biodel Type 1 Diabetes Drugs Product and Services
    Table 106. Biodel Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Biodel Recent Developments/Updates
    Table 108. Biodel Competitive Strengths & Weaknesses
    Table 109. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 110. Boehringer Ingelheim Major Business
    Table 111. Boehringer Ingelheim Type 1 Diabetes Drugs Product and Services
    Table 112. Boehringer Ingelheim Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Boehringer Ingelheim Recent Developments/Updates
    Table 114. Diamyd Therapeutics AB Basic Information, Manufacturing Base and Competitors
    Table 115. Diamyd Therapeutics AB Major Business
    Table 116. Diamyd Therapeutics AB Type 1 Diabetes Drugs Product and Services
    Table 117. Diamyd Therapeutics AB Type 1 Diabetes Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Type 1 Diabetes Drugs Upstream (Raw Materials)
    Table 119. Type 1 Diabetes Drugs Typical Customers
    Table 120. Type 1 Diabetes Drugs Typical Distributors
List of Figure
    Figure 1. Type 1 Diabetes Drugs Picture
    Figure 2. World Type 1 Diabetes Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Type 1 Diabetes Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Type 1 Diabetes Drugs Production (2018-2029) & (K Units)
    Figure 5. World Type 1 Diabetes Drugs Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Type 1 Diabetes Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Type 1 Diabetes Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Type 1 Diabetes Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Type 1 Diabetes Drugs Production (2018-2029) & (K Units)
    Figure 10. China Type 1 Diabetes Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Type 1 Diabetes Drugs Production (2018-2029) & (K Units)
    Figure 12. Type 1 Diabetes Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Type 1 Diabetes Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Type 1 Diabetes Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Type 1 Diabetes Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Type 1 Diabetes Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Type 1 Diabetes Drugs Markets in 2022
    Figure 26. United States VS China: Type 1 Diabetes Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Type 1 Diabetes Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Type 1 Diabetes Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Type 1 Diabetes Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Type 1 Diabetes Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Type 1 Diabetes Drugs Production Market Share 2022
    Figure 32. World Type 1 Diabetes Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Type 1 Diabetes Drugs Production Value Market Share by Type in 2022
    Figure 34. Insulins
    Figure 35. Others
    Figure 36. World Type 1 Diabetes Drugs Production Market Share by Type (2018-2029)
    Figure 37. World Type 1 Diabetes Drugs Production Value Market Share by Type (2018-2029)
    Figure 38. World Type 1 Diabetes Drugs Average Price by Type (2018-2029) & (USD/Unit)
    Figure 39. World Type 1 Diabetes Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Type 1 Diabetes Drugs Production Value Market Share by Application in 2022
    Figure 41. Drugstore
    Figure 42. Hospital
    Figure 43. Others
    Figure 44. World Type 1 Diabetes Drugs Production Market Share by Application (2018-2029)
    Figure 45. World Type 1 Diabetes Drugs Production Value Market Share by Application (2018-2029)
    Figure 46. World Type 1 Diabetes Drugs Average Price by Application (2018-2029) & (USD/Unit)
    Figure 47. Type 1 Diabetes Drugs Industry Chain
    Figure 48. Type 1 Diabetes Drugs Procurement Model
    Figure 49. Type 1 Diabetes Drugs Sales Model
    Figure 50. Type 1 Diabetes Drugs Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Type 1 Diabetes Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Type 1 Diabetes Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 25 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Type 1 Diabetes Drugs market size was valued at USD 28640 million in 2023 and is forecast to a readjusted size of USD 51380 million by 2030 with a CAGR of 8.7% during review period.

Product Tags

Type 1 Diabetes Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>